The global peritoneal dialysis market size reached US$ 16.4 Billion in 2022. Looking forward, the analyst expects the market to reach US$ 22.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.02% during 2023-2028.
Peritoneal dialysis (PD) represents a type of kidney failure treatment procedure wherein a soft plastic tube or catheter is placed in the abdominal lining or belly through surgery. Once it is positioned, a sterile cleansing fluid is transmitted by the duct that helps filter the blood inside an individual’s body by removing waste products. After a period of time, the liquid and filtered unwanted components flow out of the abdomen and are discarded. PD is differentiated into continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis (CCPD). These approaches offer treatment flexibility, reduce the need to visit dialysis centers, and provide better clinical outcomes, resulting in lesser medications and fewer food restrictions. Apart from this, it can be carried out at home and is needle-free; thus, PD is used by hospitals and healthcare centers to treat kidney failures.
Peritoneal dialysis (PD) represents a type of kidney failure treatment procedure wherein a soft plastic tube or catheter is placed in the abdominal lining or belly through surgery. Once it is positioned, a sterile cleansing fluid is transmitted by the duct that helps filter the blood inside an individual’s body by removing waste products. After a period of time, the liquid and filtered unwanted components flow out of the abdomen and are discarded. PD is differentiated into continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis (CCPD). These approaches offer treatment flexibility, reduce the need to visit dialysis centers, and provide better clinical outcomes, resulting in lesser medications and fewer food restrictions. Apart from this, it can be carried out at home and is needle-free; thus, PD is used by hospitals and healthcare centers to treat kidney failures.
Peritoneal Dialysis Market Trends:
The increasing prevalence of hypertension, diabetes, and end-stage renal disease (ESRD), the rising shortages of kidney donors, and the emerging awareness amongst consumers regarding the risks associated with kidney transplants are majorly driving the market growth. Moreover, the growing need for home dialysis treatments, especially during the COVID-19 pandemic, is acting as another growth-inducing factor. Furthermore, the advent of various technologies, such as automated peritoneal dialysis (APD), to perform renal replacement therapy for patients and multiple exchanges at night is contributing to the market growth. Such advanced products aid in lowering the incidences of peritonitis and hernias and offer better small solute clearances, especially to the geriatric population facing chronic kidney disease (CKD). Additionally, the shifting inclination of health practitioners toward PD over haemodialysis as it ensures greater patient mobility at cost-effective prices while creating fewer symptom fluctuations is propelling the market growth. Apart from this, extensive investments in research and development activities (R&D) by governments, improving reimbursement policies, and the ongoing product diversification are positively stimulating the market growth.Key Market Segmentation
The report provides an analysis of the key trends in each sub-segment of the global peritoneal dialysis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on treatment type, product and end user.Breakup by Treatment Type:
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)
Breakup by Product:
- Peritoneal Dialysis Solution
- Peritoneal Dialysis Devices
- Peritoneal Dialysis Sets
- Peritoneal Dialysis Catheters
- Others
Breakup by End User:
- Home-based Dialysis
- Dialysis Centers and Hospital-based Dialysis
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amecath, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medical Components Inc., Medionics International Inc., Medtronic plc, Merit Medical Systems Inc., Mitra Industries Pvt. Ltd., Newsol Technologies Inc., Nipro Canada (Nipro Medical Corporation), Poly Medicure Limited, Terumo Corporation and Utah Medical Products Inc.Key Questions Answered in This Report:
- How has the global peritoneal dialysis market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global peritoneal dialysis market?
- What are the key regional markets?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global peritoneal dialysis market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Peritoneal Dialysis Market
6 Market Breakup by Treatment Type
7 Market Breakup by Product
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Amecath
- Baxter International Inc.
- Fresenius Medical Care AG & Co. KGaA
- Medical Components Inc.
- Medionics International Inc.
- Medtronic plc
- Merit Medical Systems Inc.
- Mitra Industries Pvt. Ltd.
- Newsol Technologies Inc.
- Nipro Canada (Nipro Medical Corporation)
- Poly Medicure Limited
- Terumo Corporation
- Utah Medical Products Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 146 |
| Published | October 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 16.4 Billion |
| Forecasted Market Value ( USD | $ 22.3 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
